17 February 2021
Genomics and biotechnology company 23andMe has announced that it is going public through a deal with Virgin.
Launched in 2006, 23andMe offers genetic testing services to consumers. By providing a saliva sample, customers can find out about their ancestry and predisposition to certain health conditions.
Vin comments on the data privacy risks this deal brings, and the business obligations involved with working with genetic data.